These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21544807)

  • 1. Aberrations of a cell adhesion molecule CADM4 in renal clear cell carcinoma.
    Nagata M; Sakurai-Yageta M; Yamada D; Goto A; Ito A; Fukuhara H; Kume H; Morikawa T; Fukayama M; Homma Y; Murakami Y
    Int J Cancer; 2012 Mar; 130(6):1329-37. PubMed ID: 21544807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma.
    Yamada D; Kikuchi S; Williams YN; Sakurai-Yageta M; Masuda M; Maruyama T; Tomita K; Gutmann DH; Kakizoe T; Kitamura T; Kanai Y; Murakami Y
    Int J Cancer; 2006 Feb; 118(4):916-23. PubMed ID: 16152585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Contribution of Cadm1-Cadm3 Cell Adhesion Molecules to Peripheral Myelinated Axons.
    Sukhanov N; Vainshtein A; Eshed-Eisenbach Y; Peles E
    J Neurosci; 2021 Feb; 41(7):1393-1400. PubMed ID: 33397712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
    Luo F; Zhao Y; Liu J
    Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinoma.
    Gutwein P; Schramme A; Voss B; Abdel-Bakky MS; Doberstein K; Ludwig A; Altevogt P; Hansmann ML; Moch H; Kristiansen G; Pfeilschifter J
    Biochem Biophys Res Commun; 2009 Mar; 380(2):387-91. PubMed ID: 19250634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic adhesion molecules in Cadm family at the neuromuscular junction.
    Tanabe Y; Fujita E; Hayashi YK; Zhu X; Lubbert H; Mezaki Y; Senoo H; Momoi T
    Cell Biol Int; 2013 Jul; 37(7):731-6. PubMed ID: 23505055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer.
    Takahashi Y; Iwai M; Kawai T; Arakawa A; Ito T; Sakurai-Yageta M; Ito A; Goto A; Saito M; Kasumi F; Murakami Y
    Breast Cancer; 2012 Jul; 19(3):242-52. PubMed ID: 21526423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of CADM1 and CADM4 are associated with advanced stage breast cancer.
    Saito M; Goto A; Abe N; Saito K; Maeda D; Ohtake T; Murakami Y; Takenoshita S
    Oncol Lett; 2018 Feb; 15(2):2401-2406. PubMed ID: 29434950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma.
    Kawakami T; Chano T; Minami K; Okabe H; Okada Y; Okamoto K
    Hum Mol Genet; 2006 Mar; 15(6):821-30. PubMed ID: 16439445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis.
    Murakami Y
    Cancer Sci; 2005 Sep; 96(9):543-52. PubMed ID: 16128739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preneoplastic and neoplastic lesions of rat hereditary renal cell tumors express markers of proximal and distal nephron.
    Wolf DC; Whiteley HE; Everitt JI
    Vet Pathol; 1995 Jul; 32(4):379-86. PubMed ID: 7483212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
    Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J
    Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a splicing variant of the CADM1 specific to small cell lung cancer.
    Kikuchi S; Iwai M; Sakurai-Yageta M; Tsuboi Y; Ito T; Maruyama T; Tsuda H; Kanai Y; Onizuka M; Sato Y; Murakami Y
    Cancer Sci; 2012 Jun; 103(6):1051-7. PubMed ID: 22429880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic deletion of Cadm4 results in myelin abnormalities resembling Charcot-Marie-Tooth neuropathy.
    Golan N; Kartvelishvily E; Spiegel I; Salomon D; Sabanay H; Rechav K; Vainshtein A; Frechter S; Maik-Rachline G; Eshed-Eisenbach Y; Momoi T; Peles E
    J Neurosci; 2013 Jul; 33(27):10950-61. PubMed ID: 23825401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor CADM1 is involved in epithelial cell structure.
    Sakurai-Yageta M; Masuda M; Tsuboi Y; Ito A; Murakami Y
    Biochem Biophys Res Commun; 2009 Dec; 390(3):977-82. PubMed ID: 19854157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
    Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
    J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell adhesion and prostate tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4.
    Williams YN; Masuda M; Sakurai-Yageta M; Maruyama T; Shibuya M; Murakami Y
    Oncogene; 2006 Mar; 25(10):1446-53. PubMed ID: 16261159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study.
    Hughson MD; Johnson LD; Silva FG; Kovacs G
    Mod Pathol; 1993 Jul; 6(4):449-56. PubMed ID: 8415591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.